Filtered By:
Specialty: International Medicine & Public Health
Management: Budgets

This page shows you your search results in order of date.

Order by Relevance | Date

Total 23 results found since Jan 2013.

EE460 A Budget Impact Model to Evaluate the Economic Impact of Treating Walking Impairment in Chronic Stroke, A US Perspective
MR-001 is an investigational, at-home rehabilitation system designed to improve walking and ambulation status in adults with chronic stroke. A budget impact model (BIM) was developed to evaluate the economic impact associated with the reimbursement of MR-001 from a US payer perspective.
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: S. Kane, N. Jayawardena, M. Bourque, J. Lavanture, H. Roberts Source Type: research

HTA42 The Budget Impact Analysis of Acute Stroke Centre Expansion in Ministry of Health Malaysia
This study aimed to assess the budget impact analysis of expanding acute stroke services/centres in the public healthcare setting in Malaysia. The number of hospitalized stroke cases in the next five years is projected from the latest national stroke registry.
Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: S Thanimalai, YV Yong, I Looi, WC Law, Aziz Z Abdul Source Type: research

PND36 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Programa De Atencion medica Integral Pami in Argentina
Stroke is responsible for mortality and long-term disability in Argentina. Available treatments for stroke due to Large Vessel Occlusion (LVO) are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT). However, despite its clinical benefits, MT coverage in Argentina and PAMI is low. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of incorporating MT after IV-TPA in PAMI for the elderly.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: P. Lylyk, J. Cirio, C. Toranzo, E.C. Aiello, D. Paredes, J. Valencia Source Type: research

PND28 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Obras Sociales and Empresas De Medicina Prepaga in Argentina
Stroke is associated with high clinical and economic burden of disease. Available treatments for stroke due to Large Vessel Occlusion (LVO) in Argentina are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT). Despite its clinical benefits, MT coverage in Argentina is low. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of incorporating MT after IV-TPA in Obras Sociales and Empresas de Medicina Prepaga (EMP) in Argentina.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: P. Lylyk, J. Cirio, C. Toranzo, E.C. Aiello, D. Paredes, J. Valencia Source Type: research

Budget Impact Analysis (BIA) Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)
To estimate financial consequences of reimbursement of mechanical thrombectomy (MT) using a stent retriever in patients with AIS in Poland.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Pochopien, T Fundament, G Niesyczynski, A Lembas, R Plisko Source Type: research

Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey
Cerebrovascular diseases are the sixth cause of total DALYs in Turkey and the Turkish Social Security Institution (SSI) faces a challenge on reimbursement decisions for treatment. Alteplase is a recombinant human tissue plasminogen activator indicated for treatment of acute ischemic stroke (AIS). Clinical trials have proved efficacy in reducing 90-day disability measured by the Modified Rankin Score (mRS) if administered within 4,5 hours of onset of symptoms. The agent is used as an addition to Standard of Care (SoC).
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Tatar, A Şentürk, E Tetik, L Yıldız, J Cheynel Source Type: research

Budget Impact of Post-Stroke Dysphagia: Database Analyses of Hospital Discharges In France And Switzerland
Oropharyngeal dysphagia is prevalent in hospitalized post-stroke patients and is associated with increased mortality and comorbidities. The aim of our analysis was to evaluate the impact of dysphagia on Length of Hospital Stay (LOS) and costs. The hospital perspective was used to assess costs.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: N Muehlemann, L de L éotoing, B Jouaneton, J Fernandes, M Arnold, G Kägi Source Type: research

Mind the Treatment Gap
getty images/ istock photoBy Vani S. Kulkarni and Raghav GaihaPHILADELPHIA AND NEW DELHI, Apr 14 2017 (IPS)Implementation of the Mental Healthcare Act will require a restructuring of health-care services The Mental Healthcare Bill, 2016, which was passed in the Lok Sabha on March 27, 2017, has been hailed as a momentous reform. According to the Bill, every person will have the right to access mental health care operated or funded by the government; good quality and affordable health care; equality of treatment and protection from inhuman practices; access to legal services; and right to complain against coercion and cruelt...
Source: IPS Inter Press Service - Health - April 14, 2017 Category: Global & Universal Authors: Vani Kulkarni and Raghav Gaiha Tags: Asia-Pacific Development & Aid Gender Gender Violence Headlines Health Human Rights Women's Health Source Type: news

Pharmacoeconomic Analysis of Naftidrofuryl for Ischemic Stroke Treatment
Perform the pharmacoeconomic analysis of including naftidrofuryl into the Russian standards for treatment and rehabilitation of patients suffering from ischemic stroke by means of performing Cost Minimization Analysis (CMA) and Budget Impact Analysis (BIA).
Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: D Belousov, A Cheberda Source Type: research

The Uptake of Non-Vitamin K Oral Anticoagulants in Ireland: Balancing Cost-Effectiveness Analysis and Budget Impact
For many years vitamin K antagonists (usually warfarin) were the only oral anticoagulants available to reduce stroke risk in Atrial fibrillation (AF). The non-vitamin K oral anticoagulants (NOACs) were first licensed in Ireland for stroke prevention in non-valvular AF with the approval of dabigatran etexilate in 2011. Rivaroxaban followed later that year, apixaban in 2013 and edoxaban in 2015. The National Centre for Pharmacoeconomics (NCPE) reviewed all the NOACs for cost-effectiveness prior to reimbursement approval in Ireland.
Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: M Barry, S Clarke, N Geraghty Source Type: research

Using Smarter Stoves to Combat Household Air Pollution
By Bjørn LomborgMar 16 2016 (The Daily Star, Bangladesh)When it comes to cooking indoors over open fires, the harmful health effects can be equal to smoking two packs of cigarettes a day. This indoor air pollution plagues nearly nine out of every 10 Bangladeshi households, which use wood and other biofuels to cook inside. Over time, exposure to smoke from indoor cooking leads to deadly diseases such as lung cancer, stroke, and heart disease. This is why it’s the most deadly environmental problem in the world. In Bangladesh, such indoor air pollution is responsible for 10-15 percent of all deaths.It may seem obvious ...
Source: IPS Inter Press Service - Health - March 16, 2016 Category: Global & Universal Authors: Bjorn Lomborg Tags: Asia-Pacific Environment Health TerraViva United Nations Source Type: news

Budget Impact Analysis of The Use of Alteplase In The Treatment of Acute Ischaemic Stroke In Mexico
To estimate the economic impact of the use of alteplase versus best supportive care (BSC) in patients with acute ischemic stroke in Mexico.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: JL Huicochea-Bartelt, E Palacios, L Zapata, S Herran Tags: CARDIOVASCULAR DISORDERS – Cost Studies Source Type: research

Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation
To conduct budget impact analysis of neurotrophic and neuroprotective drug cerebrolysin with standard therapy compared to standard therapy only of ischemic stroke of moderate and severe degrees of severity according to the Russian healthcare system.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Kulikov, G Abdrashitova Source Type: research

Real-World Data And Budget Impact Analysis for Incobotulinum Toxin A and Onabotulinum Toxin A for Upper Limb Post-Stroke Spasticity At A Uk Centre
Botulinum toxins (BT) are a valuable treatment option for patients with post-stroke upper-limb spasticity (PS-ULS), which affects 33,000 patients in the UK. Xeomin (incobotulinum toxin A) and Botox (onabotulinum toxin A) are two BTs licensed for the treatment of PS-ULS. The treatment costs for Xeomin and Botox will depend on their real-world usage.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Robertson, P Datta, J Kusel, S Page, J Soon Source Type: research

Budget Impact Analysis of Botulinium Toxin Type A In Treatment of Post-Stroke Spasticity In The Russian Federation
To conduct budget impact analysis of abobotulinumtoxinA, onabotulinumtoxinA, incobotulinumtoxinA in patients with post-stroke spasticity in Russia for 1-year period. Physical therapy was used in all therapy schemes.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: R. Yagudina, A. Kulikov, D. Ugrekhelidze Source Type: research